Considering the role of the Akt/mTOR pathway in DNA damage repair, we hypothesize that RAD21 affects the ovarian cancer cell response to PARP inhibitors not only by mediating sister chromatid cohesion but also by activating the Akt/mTOR pathway. Here, RAD21 is linked to ovarian cancer.